BR0010558A - Methods to predict and / or diagnose gastric cancer risk - Google Patents

Methods to predict and / or diagnose gastric cancer risk

Info

Publication number
BR0010558A
BR0010558A BR0010558-9A BR0010558A BR0010558A BR 0010558 A BR0010558 A BR 0010558A BR 0010558 A BR0010558 A BR 0010558A BR 0010558 A BR0010558 A BR 0010558A
Authority
BR
Brazil
Prior art keywords
methods
gastric cancer
predict
cancer risk
risk
Prior art date
Application number
BR0010558-9A
Other languages
Portuguese (pt)
Inventor
Robert Llewellyn Clancy
Gerald Pang
Original Assignee
Onco Alert Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onco Alert Pty Ltd filed Critical Onco Alert Pty Ltd
Publication of BR0010558A publication Critical patent/BR0010558A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: "MéTODOS PARA PROGNOSTICAR E/OU DIAGNOSTICAR O RISCO DE CâNCER GáSTRICO". A presente invenção refere-se a métodos de prognosticar o risco de desenvolver câncer e em particular a um método para diagnosticar e/ou prognosticar o risco de desenvolver câncer gástrico em um indivíduo infectado com Heliobacter.Invention Patent: "METHODS FOR PROGNOSING AND / OR DIAGNOSING THE RISK OF GASTRIC CANCER". The present invention relates to methods of predicting the risk of developing cancer and in particular a method of diagnosing and / or predicting the risk of developing gastric cancer in an individual infected with Heliobacter.

BR0010558-9A 1999-05-14 2000-05-15 Methods to predict and / or diagnose gastric cancer risk BR0010558A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Publications (1)

Publication Number Publication Date
BR0010558A true BR0010558A (en) 2002-02-19

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010558-9A BR0010558A (en) 1999-05-14 2000-05-15 Methods to predict and / or diagnose gastric cancer risk

Country Status (10)

Country Link
EP (1) EP1183540A4 (en)
JP (1) JP2002544520A (en)
KR (1) KR20020033093A (en)
CN (1) CN1355885A (en)
AU (1) AUPQ037799A0 (en)
BR (1) BR0010558A (en)
CA (1) CA2372761A1 (en)
HK (1) HK1044988A1 (en)
MX (1) MXPA01011721A (en)
WO (1) WO2000070348A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
JP2014530350A (en) * 2011-09-14 2014-11-17 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ Means and methods for assessing nephrotoxicity
JP6707248B2 (en) * 2013-12-05 2020-06-10 学校法人北里研究所 Gastric cancer cell detection method and gastric cancer cell detection kit
RU2706118C1 (en) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Method for prediction of precancer diseases of stomach
CN117143234B (en) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 Monoclonal antibody against rat interleukin-4 protein and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012965A1 (en) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Helicobacter pylori diagnostic methods and kits
IT1289578B1 (en) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa IMMUNOPURIFICATION OF AN ANTIGEN WITH AN APPARENT MOLECULAR WEIGHT OF 16 + - 2 KDA OF THE HELICOBACTER PYLORI AND METHODS FOR ITS

Also Published As

Publication number Publication date
WO2000070348A1 (en) 2000-11-23
JP2002544520A (en) 2002-12-24
CN1355885A (en) 2002-06-26
CA2372761A1 (en) 2000-11-23
KR20020033093A (en) 2002-05-04
MXPA01011721A (en) 2003-09-10
EP1183540A4 (en) 2007-07-04
AUPQ037799A0 (en) 1999-06-10
HK1044988A1 (en) 2002-11-08
EP1183540A1 (en) 2002-03-06

Similar Documents

Publication Publication Date Title
CY1112261T1 (en) INSTRUMENT FOR DETERMINING THE PROFILE OF A PERSONAL RISK FOR ATHLETIC DISEASE
BR9907256A (en) Proteasome 20s beta-ketoamide inhibitors
EP1466179A4 (en) Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same
WO2000035436A3 (en) Treatment of arthritis with mek inhibitors
TR200102499T2 (en) As a combination therapy in the treatment of neoplasia, a cyclooxygenase-2 inhibitor and a method of using one or more antineoplastic agents
ATE424560T1 (en) MARKER FOR NEUROMYELITIS OPTICA
HK1030018A1 (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
BR0112644A (en) Method of identifying cancer markers and their uses in cancer diagnosis
DE60228557D1 (en) CANDIDA-PROOF
BR0115715A (en) Nucleic acid and polypeptide expression analysis useful in prostate cancer diagnosis and treatment
DK1075277T3 (en) Methods for detecting and inhibiting angiogenesis
BR0014150A (en) Diagnostics and therapeutics for osteoporosis
DE60322848D1 (en) SYSTEM FOR CONTINUOUS PERFORMANCE TESTS
BR0010558A (en) Methods to predict and / or diagnose gastric cancer risk
BRPI0512948A (en) biomarkers of alzheimer's disease
NO20052553L (en) Cobalaminanalyse.
BRPI0414365A (en) compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and / or diabetes.
BR9913770A (en) Test procedure for determining cobalamin bound to transcobalamin ii (tcii) in a body sample, kit for use in a diagnostic assay, and use of holo-tc ii
ATE275268T1 (en) METHOD FOR DIAGNOSIS OF SJÖGREN'S SYNDROME
BR0115689A (en) Nucleic acid and polypeptide differentiation inhibitor expression analysis useful in the diagnosis and treatment of prostate cancer
NO20002176D0 (en) Diagnosis and therapy of chronic obstructive airway disease
ATE515576T1 (en) PROTEIN C POLYMORPHISMS
BR0308117A (en) Avidin dimers effective in increasing radioactive biotin concentration in pre-directed radioimmunotherapy
BRPI0415562A (en) reagent for diagnostic and / or prognostic evaluation of carcinoma, methods for determining p-lap which is a prognostic factor in carcinoma, and for prognostic evaluation of carcinoma, and immunoassay kit for determining the amount of p-lap present in carcinoma tissues. carcinoma
BR0313667A (en) Processes for diagnosing dementia-related neurological disorders

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADDE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.